Transfusion-transmitted viral infections

New England Journal of Medicine

Volumn 335, Issue 21, 1996, Pages 1609-1610

  Couroucé, Anne Marie ^a   Pileonee, Josiane ^b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b Reseau National de Sante Publique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INCIDENCE; INFECTION RISK; LETTER; PRIORITY JOURNAL; SEROCONVERSION; VIRUS INFECTION;

BLOOD TRANSFUSION; DELTARETROVIRUS INFECTIONS; DISEASE TRANSMISSION, HORIZONTAL; FRANCE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; RISK; UNITED STATES; VIRUS DISEASES;

EID: 0029829666     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199611213352115     Document Type: Article

References (6)

1. Schreiber GB, Busch MP, Klcinman SH, Korclitz JI. The risk of transfusion-transmitted viral infections. N Kngl J Med 1996;334:1685-90.
2. Barrera IM, Francis B, Ercilla G, et al. Improved detection of ami HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 1995; 68:15 8.
3. Minims LT, Mosley JW, Hollinger FB, et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993;307:1095 -7.
4. Fong TL, Di Bisceglie AM, Biswas R, et al. High levels of viral replica tion during acute hepatitis B infection predict progression to chronicity. J Mcd Virol 1994;43:155-8.
5. Courouce AM, Le Marrec N, Girault A, Ducamp S, Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second and third-generation anti-HCV assays. Trans fusion 1994;34:790 5.
6. Pillonel J, Courouce AM, Elghouzzi MH, Piquet Y, Lemaire JM. Sero conversions to HTLV in blood donors. Vox Sang 1996;70:47.